Patients' perceptions, attitudes, and experiences about the management of mild-to-moderate ulcerative colitis

被引:14
|
作者
Casellas, Francesc [1 ]
Vicens, Daniel Ginard [2 ]
Riestra Menendez, Sabino [3 ]
Alfaro Oliver, Noelia [4 ]
机构
[1] Hosp Univ Vall dHebron, Ciberehd, Crohn Colitis Care Unit, Barcelona 08035, Spain
[2] Hosp Univ Son Espases, Dept Gastroenterol, Palma de Mallorca 07120, Islas Baleares, Spain
[3] Hosp Univ Cent Asturias, Dept Gastroenterol, Oviedo 33006, Asturias, Spain
[4] Adv Res Tech Hlth Serv TAISS, Madrid 28034, Spain
关键词
Ulcerative colitis; Management of the disease; Treatment of the disease; Quality of life; Patient satisfaction; INFLAMMATORY-BOWEL-DISEASE; HEALTH-CARE; SATISFACTION; PERSPECTIVE; COPENHAGEN;
D O I
10.1016/j.crohns.2014.02.013
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: To establish the perceptions, attitudes, experiences, and satisfaction with clinical management of ulcerative colitis (UC) patients, particularly in aspects related to treatment. Methods: A qualitative, descriptive, exploratory study. A discussion group was performed in patients who were in remission according to the criteria of the Mayo index, who had never taken biologics or corticosteroids in the past year. They were selected by: course (mild/moderate), time since onset (under 5 years/5 to 9 years/10 years or more), follow-up area (primary care [PC]-hospital/PC-specialist care/hospital), treatment (yes/no), UC care unit (yes/no), belongs to patient associations (yes/no) and sex. A descriptive-interpretative content analysis was performed to detect emerging categories, providing them with an explanatory framework. Results: Diagnostic delay was detected due to lack of clinical suspicion from PC and delayed diagnostic tests. For follow-up, patients prefer care on demand, channeled through remote care, which helps to resolve questions, problems with treatment, or when a relapse occurs, minimizing visits to the hospital. They demand more information, both about UC and treatment. The expectations about treatments are limited, so they mainly requested efficacy and safety. Conclusion: The results suggest the importance of developing strategies to facilitate care on demand and remote care, and to investigate on effective and safe treatments to minimize the detriment to quality of life of patients. These strategies should guarantee fast care and, together with safe and effective treatments, optimize the management of UC patients. (C) 2014 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1097 / 1107
页数:11
相关论文
共 50 条
  • [41] Design of Clinical Trials for Mild to Moderate Ulcerative Colitis
    Sedano, Rocio
    Jairath, Vipul
    Ma, Christopher
    GASTROENTEROLOGY, 2022, 162 (04) : 1005 - 1018
  • [42] 'Treat to Target' in Mild to Moderate Ulcerative Colitis: Evidence to Support this Strategy
    Dal Buono, Arianna
    Roda, Giulia
    Argollo, Marjorie
    Paridaens, Kristine
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    CURRENT DRUG TARGETS, 2021, 22 (01) : 117 - 125
  • [43] Budesonide Foam Induces Remission in Patients With Mild to Moderate Ulcerative Proctitis and Ulcerative Proctosigmoiditis
    Sandborn, William J.
    Bosworth, Brian
    Zakko, Salam
    Gordon, Glenn L.
    Clemmons, David R.
    Golden, Pamela L.
    Rolleri, Robert L.
    Yu, Jing
    Barrett, Andrew C.
    Bortey, Enoch
    Paterson, Craig
    Forbes, William P.
    GASTROENTEROLOGY, 2015, 148 (04) : 740 - U328
  • [44] Budesonide MMX®: A Review of Its Use in Patients with Mild to Moderate Ulcerative Colitis
    Sheridan M. Hoy
    Drugs, 2015, 75 : 879 - 886
  • [45] Spicing up the Treatment of Mild to Moderate Ulcerative Colitis
    Bernstein, Charles N.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (08) : 1450 - 1452
  • [46] Clinical Study on Saccharomyces Boulardii in the Treatment of Patients with Mild to Moderate Ulcerative Colitis
    Tang, Hai-Ying
    Wu, Hao
    Mao, Jing-Wei
    Zhu, Lei
    Li, Na
    Wang, Ying-De
    11TH IEEE INTERNATIONAL CONFERENCE ON CONTROL AND AUTOMATION (ICCA), 2014, : 734 - 737
  • [47] Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - A randomized, placebo-controlled, pilot study
    Singla, Vikas
    Mouli, Venigalla Pratap
    Garg, Sushil Kumar
    Rai, Tarun
    Choudhury, Bikash Narayan
    Vernna, Prashant
    Deb, Rachana
    Tiwari, Veena
    Rohatgi, Sarika
    Dhingra, Rajan
    Kedia, Saurabh
    Sharma, Piyush Kumar
    Makharia, Govind
    Ahuja, Vineet
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (03) : 208 - 214
  • [48] The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative Colitis
    Travis, Simon
    Potts Bleakman, Alison
    Dubinsky, Marla C.
    Schreiber, Stefan
    Panaccione, Remo
    Hibi, Toshifumi
    Gibble, Theresa Hunter
    Kayhan, Cem
    Atkinson, Christian
    Sapin, Christophe
    Flynn, Eoin J.
    Rubin, David T.
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (06) : 939 - 949
  • [49] Point-counterpoint: Are we overtreating patients with mild ulcerative colitis?
    Waljee, Akbar K.
    Stidham, Ryan W.
    Higgins, Peter D. R.
    Vijan, Sandeep
    Saini, Sameer D.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (01) : 80 - 84
  • [50] Traditional Chinese medicine for mild-to-moderate ulcerative colitis Protocol for a network meta-analysis of randomized controlled trials
    Shen, Zhaofeng
    Zhou, Qing
    Ni, Yingjun
    He, Weiming
    Shen, Hong
    Zhu, Lei
    MEDICINE, 2019, 98 (33)